Register Login

ORUKA THERAPEUTICS, INC. (ORKA)

Agarwal Arjun 🟡 adjusted position in 9.9K shares (2 derivative) of Oruka Therapeutics, Inc. (ORKA) at $70.34 Transaction Date: Jun 12, 2026 | Filing ID: 000064

Full text
Register to leave comments
  • News bot June 15, 2026, 10:57 p.m.

    🔍 Agarwal Arjun (Executive)

    Company: Oruka Therapeutics, Inc. (ORKA)

    Report Date: 2026-06-12

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 9,459
    • Total shares sold: 19,313

    Detailed Transactions and Holdings:

    • Acquired 8,000 shares of Common Stock at $12.5 per share (Direct)
      Date: 2026-06-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,294.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,459 shares of Common Stock at $34.39 per share (Direct)
      Date: 2026-06-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,753.00 | transaction_form_type: 4
    • Sold 1,859 shares of Common Stock at $68.3419 per share (Direct)
      Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,894.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Sold 4,340 shares of Common Stock at $69.8512 per share (Direct)
      Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,554.00 | transaction_form_type: 4 | Footnotes: F2, F4
    • Sold 3,260 shares of Common Stock at $70.3392 per share (Direct)
      Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,294.00 | transaction_form_type: 4 | Footnotes: F2, F5
    • Sold 395 shares of Common Stock at $69.69 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,899.00 | transaction_form_type: 4 | Footnotes: F6
    • Sold 8,000 shares of Employee Stock Option (right to buy) at $12.5 per share (Derivative)
      Date: 2026-06-12 | Code: M | Expires: 2035-01-21 | equity_swap_involved: 0 | shares_owned_after: 110,000.00 | transaction_form_type: 4 | Footnotes: F7
    • Sold 1,459 shares of Employee Stock Option (right to buy) at $34.39 per share (Derivative)
      Date: 2026-06-12 | Code: M | Expires: 2036-01-22 | equity_swap_involved: 0 | shares_owned_after: 62,708.00 | transaction_form_type: 4 | Footnotes: F8

    Footnotes:

    • F1: Includes 888 shares acquired under the Oruka Therapeutics, Inc. stock purchase plan on June 8, 2026.
    • F2: These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.87 to $68.71, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
    • F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $70.06, inclusive.
    • F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.07 to $70.86, inclusive.
    • F6: The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.
    • F7: The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.
    • F8: The option vests as to 1/48 of the underlying shares monthly from January 1, 2026.

Search

News categories